China, the only major economy witnessing a huge wave of fresh Covid infections, is in talks with Pfizer for it COVID-19 antiviral drug, said Reuters citing sources.

China in talks with Pfizer for COVID-19 anti-viral medicine paxlovid: Report

AstraZeneca's COVID-19 antibody combination Evusheld has the properties to neutralise Coronavirus variants of Omicron, including the highly-contagious BA.2 sub-variant, the pharmaceutical company said after conducting an independent lab study.

AstraZeneca claims its COVID-19 antibody concoction can neutralise BA.2 Omicron sub-variant

Drugs Controller General of India (DCGI) has given its approval to an anti-Covid drug developed by Defence Research and Development Organisation (DRDO). The drug has been approved for emergency use as an adjunct therapy in moderate to severe coronavirus cases.

Anti-Covid drug by India's Defence Research and Development Organisation gets regulator nod

covid-medicine

Covid Medicine, News on Covid Medicine, stories on Covid Medicine, articles on Covid Medicine, Covid Medicine stories at Wion, Covid Medicine news, Covid Medicine latest news

covid medicine

China in talks with Pfizer for COVID-19 anti-viral medicine paxlovid: Report

AstraZeneca claims its COVID-19 antibody concoction can neutralise BA.2 Omicron sub-variant

Anti-Covid drug by India's Defence Research and Development Organisation gets regulator nod